ArticleISRN oncology2012

Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer.

Shin Ogita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.